
The Washington Post @washingtonpost
The company made more opioids than any other, with generics accounting for most of Mallinckrodt’s business. To remain relevant in the increasingly competitive market, the company made Exalgo, a hydromorphone tablet, and marketed it directly to doctors. https://t.co/Wb0pV1Rvit https://t.co/6uxrfitKKt — PolitiTweet.org